|
|
US 7,531,523 B2 |
|
| Sodium channel protein type III alpha-subunit splice variant |
| Kenneth J. McCormack, Raleigh, N.C. (US); and Christopher D. Raj, San Diego, Calif. (US) |
| Assigned to Vertex Pharmaceuticals Incorporated, Cambridge, Mass. (US) |
| Filed on Feb. 17, 2006, as Appl. No. 11/357,518. |
| Claims priority of provisional application 60/654019, filed on Feb. 17, 2005. |
| Prior Publication US 2007/0048753 A1, Mar. 01, 2007 |
| Int. Cl. C12Q 1/68 (2006.01); C12P 21/06 (2006.01); C12N 15/00 (2006.01); C12N 5/00 (2006.01); C07H 21/04 (2006.01)
|